A previous study showed that high anti-GAD antibody concentrations were associated with specific clinical phenotypes, such as stiff-person syndrome, cerebellar ataxia, epilepsy, and limbic encephalitis (Munoz-Lopetegi et al., 2020). Here, GAD1 is linked to stiff-person syndrome.